This page lists the SEC filings reported by ARK Investment Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | UiPath, Inc. | 43,470,597 | 9.0% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | VERACYTE, INC. | 7,655,603 | 10.5% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Verve Therapeutics, Inc. | 7,025,116 | 8.7% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Vuzix Corp | 5,813,065 | 9.2% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Velo3D, Inc. | 13,354,810 | 5.6% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Ginkgo Bioworks Holdings, Inc. | 198,606,619 | 12.3% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Invitae Corp | 32,550,683 | 11.4% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Quantum-Si Inc | 15,519,322 | 12.7% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | SomaLogic, Inc. | 14,241,979 | 7.6% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | 2U, Inc. | 9,575,926 | 11.7% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | 908 Devices Inc. | 4,346,579 | 13.4% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Accolade, Inc. | 6,805,208 | 8.9% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Adaptive Biotechnologies Corp | 12,806,513 | 8.8% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Archer Aviation Inc. | 24,907,280 | 9.8% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Arcturus Therapeutics Holdings Inc. | 2,047,687 | 7.7% | EDGAR |
| SC 13G | 2024-01-29 | ARK Investment Management LLC | Nurix Therapeutics, Inc. | 3,194,999 | 6.6% | EDGAR |
| SC 13G | 2024-01-29 | ARK Investment Management LLC | RECURSION PHARMACEUTICALS, INC. | 20,654,287 | 9.9% | EDGAR |
| SC 13G/A | 2024-01-10 | ARK Investment Management LLC | CRISPR Therapeutics AG | 8,536,104 | 10.8% | EDGAR |
| SC 13G/A | 2023-10-10 | ARK Investment Management LLC | Archer Aviation Inc. | 23,790,372 | 11.4% | EDGAR |
| SC 13G/A | 2023-07-10 | ARK Investment Management LLC | Quantum-Si Inc | 12,754,531 | 10.5% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.